Courtney Roundy is Cofounder and CEO of Tecton Ketones, leading commercialization of R3HBG, an advanced, bioidentical ketone. With over 30 years in consumer goods and $750M+ in revenue across multiple exits, he brings deep expertise in brand building, formulation, and retail strategy. At Tecton Ketones, he drives growth across cognition, performance, and metabolic health platforms.

Diagnosed with epilepsy in 2022, Miki discovered firsthand the power of ketones as a therapeutic tool, an experience that transformed into a mission to bring metabolic health back to the mainstream. As Cofounder and COO of Tecton Ketones, she channels that conviction into pioneering work with R-3 Hydroxybutyrate Glycerides (R3HBG), positioning ketones as a foundational support for cognition, metabolic restoration, and performance. With more than two decades of executive leadership, she has built and scaled companies to acquisition, directed multi-million-dollar retail rollouts, and navigated highly regulated markets with precision.

Mike Chesne, a retired U.S. Army Special Operations veteran, founded Tecton Research and drives research for Tecton Ketones. With a background in global healthcare reform and emergency medical supply Mike continues to drive scientific exploration while supporting veteran causes through active nonprofit leadership.